Regulation of mRNA Levels of TNF-Alpha and the Alpha Chain of the High-Affinity Receptor for IgE in Mast Cells by IFN-Gamma and Alpha/Beta

International Archives of Allergy and Immunology

Volumn 110, Issue 2, 1996, Pages 114-123

  Enciso, Antonio ^a   Bissonnette, Elyse Y ^a   Befus, Dean ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Cytotoxicity; IgE receptors; Interferons; Mast cells; TNF

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; GAMMA INTERFERON; IMMUNOGLOBULIN E RECEPTOR; MESSENGER RNA; TUMOR NECROSIS FACTOR ALPHA;

ALPHA CHAIN; ANIMAL CELL; ARTICLE; GENE; GENE EXPRESSION REGULATION; INFLAMMATION; MAST CELL; NONHUMAN; PERITONEUM MAST CELL; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ANIMALS; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; INTERFERON TYPE I; INTERFERON TYPE II; LEUKEMIA, BASOPHILIC, ACUTE; MALE; MAST CELLS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, IGE; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029920784     PISSN: 10182438     EISSN: 14230097     Source Type: Journal    
DOI: 10.1159/000237275     Document Type: Article

References (46)

1. Philip R, Epstein LB: Tumor necrosis factor as immunomodulator and mediator of monocyte cytotoxicity induced by itself, gamma-interfe-ron and interleukin-1. Nature 1986;323:86-89.
2. Rosenblum MG, Donato NJ; Tumor necrosis factora:A multifaceted peptide hormone. CRC Crit Rev Immunol 1989;9:21-44.
3. Bcfus AD: Mast cells are that polymorphic. Reg Immunol 1989;2:176-187.
4. Plaut VI, Pierce JH, Watson CJ, Hanley-Hyde J, Nordan RP, Paul WE: Mast cell lines produce lymphokincs in response to cross-linkage of FceRI or to calcium ionophorcs. Nature 1989: 339:64-67.
5. Clark IA, Chaudhri G, Cowden WB : Roles of tumour necrosis factor in the illness and pathology of malaria. Trans R Soc Trop Med Hyg 1989:83:436-440.
6. De Maeyer F, Dc Maeyer-Ciuignard J: Interferons and Other Regulatory Cytokines. New York. Wiley Sons. 1988. Pp1-488.
7. Slcngcr S, Solbach W, Rollinghoff M, Bogdan C: Cytokine interactions in experimental cutaneous leishmaniasis. II. Endogenous tumor necrosis factor-a production by macrophages is induced by the synergistic action of interferon (IFN)-gamma and interleukin (II.) 4 and accounts for the antiparasitic effect mediated by IFN-gamma and 11.4. Eur.l Immunol 1991:21: 1669-1675.
8. Balkwill FR: The regulatory role of interferons in the human response; in Taylor-Papadimitriou J (ed): Interferons: Their Impact in Biology and Medicine. Oxford. Oxford University Press. 1985, pp 61-80.
9. Bissonnette EY, Bcfus AD: Inhibition of mast cell-mediated cytotoxicity by IFN-u/p and -y. J Immunol 1990;145:3385-3390.
10. Witt PL, Spear GT, Helgeson DO, Lindstrom MJ, Smalley RY, Borden EC: Basal and interferon-induced 2'5’-oligoadenylatc synthetase in human monocytes, lymphocytes, and peritoneal macrophages. J Interferon Res 1990:10: 393-402.
11. Blanar MA, Baldwin AS Jr., Flavell RA, Sharp PA: A gamma-interferon-induccd factor that binds the interferon response sequence of the MHC class I gene. H-2Kb. EMBO J 1989:8: 1139-1144.
12. Tanaka M, Kimura K, Yoshida S: Inhibition of mammalian DNA polymerases by recombinant alpha-imerferon and gamma-interfcron. Cancer Res 1987:47:5971-5974.
13. Clemens MJ. McNurlan MA: Regulation ofcell proliferation by interferons. Biochem J 1985: 266:345-360.
14. Skurkovich S, Skurkovich B, Bellanti JA, Ba-nerjee DK: Interferon increases IgE binding to basophils. Ann Allergy 1983:50:305-308.
15. Lee TDG, Shanahan F, Miller HRP, Bienenstock J, Bcfus AD: Intestinal mucosal mast cells: Isolation from rat lamina propria and purification using unit gravity velocity sedimentation. Immunology 1985:55:721-728.
16. Zheng Y. Chan BMC. Rector ES. Bcrczi I. Frocse A: Establishment and characterization of hybrid rat mast cells. Exp Cell Res 1991; 194: 301-309.
17. Befus AD. Bienenstock J. Dcnburg JA: Mast Cells: Differentiation and Heterogeneity. New' York. Raven Press. 1986. pp 1426.
18. Pross IIF. Baines MG. Rubin P. Shragge P. Patterson MS: Spontaneous human lymphocyte-mediated cytotoxicity against tumor target cells. IX. The quantification of natural killer cell activity. J Clin Immunol 1981:1:51-63.
19. Gray PW, Aggarwall BB, Benton CV, Bringran TS, Henzel WJ, Jarret JA, Lenng DW, Moftat B, NG P, Suedersky LP, Palladino MA, Nedwin GE: Cloning and expression of cDNA for human lymphotoxin. a lymphokine with tumour necrosis factor activity. Nature 1984:312:721-724.
20. Chomczynski P, Sacchi N: Single-step method of RNA isolation by acid guanidinium thiocya-nate-phcnol-chloroform extraction. Anal Bio-chern 1987:162:156-159.
21. Sambrook J. Fritsch EF. Maniatis T: Molecular Cloning. A Laboratory Manual. Cold Spring Harbor. Cold Spring Harbor Laboratory Press. 1989.
22. Levy DE. Kessler DS. Pine R. Reich N. Darnell JE Jr: Interferon-induced nuclear factors that bind a shared promotor element correlate with positive and negative transcriptional control. Genes Dev 1988:2:383-393.
23. Michishita M, Yoshida Y, Uchino H, Nagata K: Induction of tumour necrosis factor-alpha and its receptors during differentiation in myeloid leukemic cells along with monocytic pathway. A possible regulatory mechanism for TNF-al-pha production. J Biol Client 1990:265:8751-8759.
24. Lin SL. Pledger J. Tamm I: Interferon effects on PDGF action; in Stewart WE. Schellenkens II (eds): The Biology of the Interferon System. New York. Elsevier. 1986. p 311.
25. Freidman RL. Stark GR: Alpha-interferon-induced transcription of 1ILA and metallothio-nein genes containing homologous upstream sequences. Nature 1985:314:637-639.
26. Dale TC. Ali Imam AM. Kerr IM. Stark GR: Rapid activation by interferon alpha of a latent DNA-binding protein present in the cytoplasm of untreated cells. Proe Natl Acad Sci USA 1989:86:1203-1207.
27. Wright TM. FarberJM: 5'regulatory region of a novel cytokine gene mediates selective activation by interferon gamma. J Exp Med 1991; 173: 417-422.
28. Colonno RJ: Accumulation of newly synthesized mRNAs in response to human fibroblast (beta) interferon. Proc Natl Acad Sei USA 1981;78:4763-4766.
29. MacDonald IIS, Kushnaryov VM, Hevner R, Scdmark JJ, Grossberg SE: Mouse beta-interfe-ron reduces RNA efflux from isolated nuclei. J Interferon Res 1986:6:247-250.
30. Schleimer RP, Fox CC, Naclerio RM, Plaut M, Creticos PS, Togias AG, Warner JA, Kagey-So-botka A, Lichtenstein LM: Role of human basophils and mast cells in the pathogenesis of the allergic diseases. J Allergy Clin Immunol 1985: 76:369-374.
31. Burd PR, Rogers HW, Gordon JR, Martin CA, Jayaraman S, Wilson SD, Dvorak AM, Galli SJ, Dorf ME: Interleukin 3-dcpendent and -independent mast cells stimulated with IgE and antigen express multiple cytokines. J Exp Med 1989;170:245-257.
32. Gordon JR, Galli SJ: Release of both preformed and newly synthesized tumor necrosis factor« (TNF-«)/cachcctin by mouse mast cells stimulated via the FctRI. A mechanism for the sustained action of mast cell-derived TNF-u during IgE-dependent biological responses. 1 Exp Med 1991:174:103-107.
33. Bradding P. Feather IH. Howarth PH. Mueller R. Roberts JA. Britten K. Bews IPA, Hunt TC, Okayama Y, Heusser CH, Bullock GR, Church MK, Holgate ST: Interleukin 4 is localized to and released by human mast cells. J Exp Med 1992:176:1381-1386.
34. M. responses. Immunol Today 1991:12:A49-A53.
35. Ida S. Hooks JJ. Siraganian RP. Notkins AL: Enhancement of IgE-mediated histamine release from human basophils by viruses: Role of interferon. J Exp Med 1977:145:892-906.
36. Swieter M. Ghali WA. Rimmer C, Befus D: In-tcrferon-a/p inhibits IgE-dependent histamine release from rat mast cells. Immunology 1989: 66:606-610.
37. Coleman JW. Buckley MG. Holliday MR. Morris AG: lntcrferon-gamma inhibits serotonin release from mouse peritoneal mast cells. Eur J Immunol 1991:21:2559-2564.
38. Takagi M. Koike K. Nakahata T: Antiproliferative effect of IFN-y on proliferation of mouse peritoneal mast cells. J Immunol 1990:145: 1880-1884.
39. Coffman RL. Carty J: A T cell activity that enhances polyclonal IgE production and its inhibition by IFN-y. J Immunol 1986;136:949-954.
40. Bissonnettc EY. Enciso JA. Befus AD: Inhibition of tumour necrosis factor alpha (TNF-u) release from mast cells by the anti-inflammatory' drugs, sodium cromoglycate and nedoeromil sodium. Clin Exp Immunol 1995:102:78-84.
41. Bissonnette F.Y. Enciso JA. Befus AD: Inhibitory' effects of sulfasalazine and its metabolites on mediator release from mast cells. J Immunol 1996:156:218-223.
42. Lack G, Rcnz H, Saloga J, Bradley KL, Loader J, Leung DYM, Larsen G, Gelfand EW: Nebulized but not parenteral IFN-y decreases IgE production and normalizes airways function in a murine model of allergen sensitization. J Immunol 1994:152:2546-2554.
43. Kinet JP. Metzger H. Hakimi J. Cochan JE: cDNA presumptively coding for theasubunit of the receptor with high affinity for immunoglobulin F. Biochemistry 1987:26:4605-4610.
44. Boltz-Nitulescu G. Wiltsckc C. Langer K. Ne-met C. Holzinger H. Gessl A. Forster O. Penner E: Augmentation of IgE receptor expression and IgE receptor-mediated phagocytosis of rat bone marrow-derived macrophages by murine interferons. Immunology 1988:63:529-535.
45. Hartnell A. Kay AB. Wardlaw AJ: IFN-y induces expression ofFcyRIII (CD l6)on human eosinophils. J Immunol 1992:148:1471-1478.
46. Kerr IM, Stark GR: The control of interferon-induciblc gene expression. FEBS Lett 1991; 285:194-198.